Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,414.90
+516.57(+1.04%)

'We sold £1.5m of product in our first week'

Lyma founder on rise of her wellness company

Tiziana Life Sciences Ltd (TLSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

0.7801

-0.0699

(-8.22%)

At close: 04:00PM EDT

0.7896

+0.01

(+1.22%)

After hours:

07:36PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	78.25M
Enterprise value	72.01M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	5.89
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-3.71

Trading information

Stock price history

Beta (5Y monthly)	0.23
52-week change ³	-1.27%
S&P500 52-week change ³	22.36%
52-week high ³	1.2700
52-week low ³	0.4100
50-day moving average ³	0.5198
200-day moving average ³	0.6080

Share statistics

Avg vol (3-month) ³	170.77k
Avg vol (10-day) ³	707.99k
Shares outstanding ⁵	100.31M
Implied shares outstanding ⁶	100.31M
Float ⁸	61.41M
% held by insiders ¹	38.03%
% held by institutions ¹	0.78%
Shares short (15 Apr 2024) ⁴	257.78k
Short ratio (15 Apr 2024) ⁴	4.98
Short % of float (15 Apr 2024) ⁴	0.42%
Short % of shares outstanding (15 Apr 2024) ⁴	0.26%
Shares short (prior month 15 Mar 2024) ⁴	365.78k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	2499:1000
Last split date ³	31 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Jun 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-44.64%
Return on equity (ttm)	-90.40%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-18.77M
Net income avi to common (ttm)	-19.5M
Diluted EPS (ttm)	-0.1800
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	6.6M
Total cash per share (mrq)	0.07
Total debt (mrq)	353k
Total debt/equity (mrq)	2.66%
Current ratio (mrq)	3.85
Book value per share (mrq)	0.13

Cash flow statement

Operating cash flow (ttm)	-19.09M
Levered free cash flow (ttm)	-10.88M